Brought to you by 
Reliant licenses Ethypharm's fenofibrate product
13 Jun 2005
Executive Summary
Reliant Pharmaceuticals has exclusively licensed North American rights to one of Ethypharm's (drug delivery) micronized fenofibrate products. Reliant will combine it with other lipid-management compounds to create a product to prevent and treat cardiovascular disease.
Deal Industry
- Biotechnology
- Pharmaceuticals
-
Pharmaceuticals
- Drug Delivery
- Specialty Pharmaceuticals
Deal Status
- Final
Deal Type
-
Alliance
- Includes Contract
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Reliant licenses Ethypharm's fenofibrate product
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice